FI884604A0 - Implanterbar, biologiskt nedbrytbart aktivmedels frigivningssystem. - Google Patents

Implanterbar, biologiskt nedbrytbart aktivmedels frigivningssystem.

Info

Publication number
FI884604A0
FI884604A0 FI884604A FI884604A FI884604A0 FI 884604 A0 FI884604 A0 FI 884604A0 FI 884604 A FI884604 A FI 884604A FI 884604 A FI884604 A FI 884604A FI 884604 A0 FI884604 A0 FI 884604A0
Authority
FI
Finland
Prior art keywords
nedbrytbart
implanterbar
frigivningssystem
aktivmedels
biologiskt
Prior art date
Application number
FI884604A
Other languages
English (en)
Other versions
FI100302B (fi
FI884604A (fi
Inventor
Herbert Stricker
Guenther Entenmann
Otto Kern
Michel Mikhail
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI884604A0 publication Critical patent/FI884604A0/fi
Publication of FI884604A publication Critical patent/FI884604A/fi
Application granted granted Critical
Publication of FI100302B publication Critical patent/FI100302B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
FI884604A 1987-10-09 1988-10-07 Poly-D,L-laktidipohjainen kantaja-aine ja menetelmä valmistaa implanto itava, biologisesti hajoava tehoaineen vapautussysteemi FI100302B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3734223 1987-10-09
DE19873734223 DE3734223A1 (de) 1987-10-09 1987-10-09 Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Publications (3)

Publication Number Publication Date
FI884604A0 true FI884604A0 (fi) 1988-10-07
FI884604A FI884604A (fi) 1989-04-10
FI100302B FI100302B (fi) 1997-11-14

Family

ID=6338006

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884604A FI100302B (fi) 1987-10-09 1988-10-07 Poly-D,L-laktidipohjainen kantaja-aine ja menetelmä valmistaa implanto itava, biologisesti hajoava tehoaineen vapautussysteemi

Country Status (17)

Country Link
EP (1) EP0311065B1 (fi)
JP (1) JP2763303B2 (fi)
KR (1) KR970006082B1 (fi)
AT (1) ATE101035T1 (fi)
AU (1) AU609194B2 (fi)
CA (1) CA1333770C (fi)
DE (2) DE3734223A1 (fi)
DK (1) DK175252B1 (fi)
ES (1) ES2061589T3 (fi)
FI (1) FI100302B (fi)
IE (1) IE62505B1 (fi)
IL (1) IL87973A (fi)
NO (1) NO176304C (fi)
NZ (1) NZ226514A (fi)
PH (1) PH30236A (fi)
PT (1) PT88703B (fi)
ZA (1) ZA887535B (fi)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5252642A (en) * 1989-03-01 1993-10-12 Biopak Technology, Ltd. Degradable impact modified polyactic acid
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
US5216050A (en) * 1988-08-08 1993-06-01 Biopak Technology, Ltd. Blends of polyactic acid
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
DK0476045T3 (da) * 1989-06-05 1996-09-16 Massachusetts Inst Technology Bionedbrydelige polymerer til lægemiddel-afgivelse i knogler
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
CH679207A5 (fi) * 1989-07-28 1992-01-15 Debiopharm Sa
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
KR920703028A (ko) * 1990-01-30 1992-12-17 에프.지.엠.헤르만스 벽으로 둘러싸이고 하나이상의 활성물질로 전체적으로 또는 부분적으로 충전된 중공공간을 포함하는 활성물질의 배출량을 조절하는 제품
DE69004415D1 (de) * 1990-03-05 1993-12-09 Minnesota Mining & Mfg Vorrichtung zur verzögerten Abgabe von pharmakologisch aktiven Verbindungen ins Ohr.
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
JP4211875B2 (ja) * 1997-04-04 2009-01-21 ノベリス・インコーポレイテッド アルミニウム合金組成物およびその製法
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
DE19908753C2 (de) * 1999-02-20 2003-10-02 Jenapharm Gmbh Bioabbaubare, injizierbare Oligomer-Polymer-Zusammensetzung
US6306425B1 (en) * 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6702849B1 (en) 1999-12-13 2004-03-09 Advanced Cardiovascular Systems, Inc. Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers
US6803443B1 (en) 2000-03-22 2004-10-12 Dainippon Ink And Chemicals, Inc. Impact modifier and polyester composition containing the modifier
EP3167872B1 (en) * 2000-07-05 2020-10-14 Allergan, Inc. Methods for treating inflammation-mediated conditions of the eye
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU2002236495B2 (en) 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US8512738B2 (en) 2004-04-30 2013-08-20 Allergan, Inc. Biodegradable intravitreal tyrosine kinase implants
US20050244458A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
CA2648479C (en) * 2006-04-06 2014-10-28 Nupathe Inc. Implants for the treatment of dopamine associated states
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
MX361709B (es) 2009-11-09 2018-12-07 Allergan Inc Composiciones y metodos para estimular el crecimiento del cabello.
JP4779169B1 (ja) * 2010-10-27 2011-09-28 Ｎｅｃインフロンティア株式会社 ボタン照明構造、電子機器
JP6511401B2 (ja) 2013-02-15 2019-05-15 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 持続型薬物送達インプラント
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
JP2020536955A (ja) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス， インコーポレイテッド 治療剤の制御放出のための埋込み可能なデポー

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (fi) * 1955-12-22
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung

Also Published As

Publication number Publication date
JPH02117A (ja) 1990-01-05
ZA887535B (en) 1990-06-27
DK561588D0 (da) 1988-10-07
FI100302B (fi) 1997-11-14
AU2352288A (en) 1989-04-13
DK175252B1 (da) 2004-07-19
JP2763303B2 (ja) 1998-06-11
IE62505B1 (en) 1995-02-08
ATE101035T1 (de) 1994-02-15
DK561588A (da) 1989-04-10
PH30236A (en) 1997-02-05
NO176304C (no) 1995-03-22
DE3887616D1 (de) 1994-03-17
IL87973A0 (en) 1989-03-31
NO884474D0 (no) 1988-10-07
PT88703A (pt) 1988-11-01
ES2061589T3 (es) 1994-12-16
CA1333770C (en) 1995-01-03
FI884604A (fi) 1989-04-10
AU609194B2 (en) 1991-04-26
PT88703B (pt) 1992-12-31
NZ226514A (en) 1990-02-26
NO884474L (no) 1989-04-10
IE883040L (en) 1989-04-09
NO176304B (no) 1994-12-05
EP0311065B1 (de) 1994-02-02
EP0311065A1 (de) 1989-04-12
KR890006222A (ko) 1989-06-12
IL87973A (en) 1992-08-18
KR970006082B1 (ko) 1997-04-23
DE3734223A1 (de) 1989-04-20

Similar Documents

Publication Publication Date Title
FI884604A (fi) Implanterbar, biologiskt nedbrytbart aktivmedels frigivningssystem.
NZ221484A (en) Starburst polymer conjugates as carriers for agricultural, pharmaceutical and other materials
DE69019817T3 (de) Trägermaterial zur Arzneimittelverabreichung.
NZ216082A (en) Prolonged-release microparticles
DE3884314D1 (de) Polymermischung mit umkehrphasen Morphologie zur kontrollierten Wirkstoffabgabe.
ES2039377T3 (es) Un supositorio.
EP0307097A3 (en) Water-insolubilized cytokines
FR2640271B1 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments
EP0380989A3 (en) Plaster for transdermal administration
DE3750656D1 (de) Katalysatoren zur Herstellung von Polyäthylen mit grosser Molekulargewichtsverteilung.
ATE175213T1 (de) Ch0ndromodulin-ii protein
MC2102A1 (fr) Application de micelles mixtes
FR2610322B1 (fr) Nouveaux derives de la pilocarpine, leur preparation et leur utilisation comme medicaments
DE58902310D1 (de) Tetrahydropyridin-derivate.
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
GB1475774A (en) Tertiary-alkylamino-lower acyl-xylidide local anesthetics

Legal Events

Date Code Title Description
FG Patent granted

Owner name: BOEHRINGER INGELHEIM KG

MA Patent expired